Compared to IL-1β, IL-18 aggravates NASH severity via altering the gut microbiota, and it has been proved in the MCD diet-induced NASH model that IL-18-deficient mice progressed to severe NASH more than the control group (Henao-Mejia et al., 2012). Here, IL18 is linked to metabolic dysfunction-associated steatohepatitis.